U.S. flag

An official website of the United States government

NM_144997.7(FLCN):c.1176+1G>C AND Birt-Hogg-Dube syndrome

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jul 25, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002038045.4

Allele description [Variation Report for NM_144997.7(FLCN):c.1176+1G>C]

NM_144997.7(FLCN):c.1176+1G>C

Gene:
FLCN:folliculin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p11.2
Genomic location:
Preferred name:
NM_144997.7(FLCN):c.1176+1G>C
HGVS:
  • NC_000017.11:g.17217068C>G
  • NG_008001.2:g.25121G>C
  • NM_001353229.2:c.1230+1G>C
  • NM_001353230.2:c.1176+1G>C
  • NM_001353231.2:c.1176+1G>C
  • NM_144997.7:c.1176+1G>CMANE SELECT
  • LRG_325t1:c.1176+1G>C
  • LRG_325:g.25121G>C
  • NC_000017.10:g.17120382C>G
  • NM_144997.5:c.1176+1G>C
Links:
dbSNP: rs1555607929
NCBI 1000 Genomes Browser:
rs1555607929
Molecular consequence:
  • NM_001353229.2:c.1230+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001353230.2:c.1176+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001353231.2:c.1176+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_144997.7:c.1176+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:
Birt-Hogg-Dube syndrome
Synonyms:
BHD syndrome; Birt Hogg Dubé syndrome
Identifiers:
MONDO: MONDO:0800444; MedGen: C0346010; Orphanet: 122; OMIM: PS135150

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV002269243Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Likely pathogenic
(Jul 25, 2021) 		germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Splicing in action: assessing disease causing sequence changes.

Baralle D, Baralle M.

J Med Genet. 2005 Oct;42(10):737-48. Review.

PubMed [citation]
PMID:
16199547
PMCID:
PMC1735933

Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome.

Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, Turner ML, Choyke PL, Sharma N, Peterson J, Morrison P, Maher ER, Walther MM, Zbar B, Linehan WM.

Am J Hum Genet. 2005 Jun;76(6):1023-33. Epub 2005 Apr 25.

PubMed [citation]
PMID:
15852235
PMCID:
PMC1196440
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002269243.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant has not been reported in the literature in individuals affected with FLCN-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change affects a donor splice site in intron 10 of the FLCN gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in FLCN are known to be pathogenic (PMID: 15852235).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024